NIGHTSEA Shifts Fluorescence Stereomicroscopy Paradigm
NIGHTSEA proudly announces the1000th installation of its Model SFA Stereomicroscope Fluorescence Adapter
NIGHTSEA proudly announces the1000th installation of its Model SFA Stereomicroscope Fluorescence Adapter
Key opinion leaders’ expertise to guide design of new gene panels for GeneReader NGS
Actionable Insights Tumor Panel enables monitoring of cancer biomarkers from plasma samples
Horizon’s X-MAN cell lines to be made available in conjunction with Ubiquigent’s ubiquitin-related Drug Discovery Services
Raman spectroscopy utilized to detect radiation damage in patients
Apply now to trial the new Lonza CytoSMART™
Siemens Healthineers will expand its portfolio with molecular testing related services and technologies for oncology and genomics
Leading-edge companies team up to accelerate cell therapy supply chain excellence
Vitrification provides excellent survivability of embryos and oocytes through the freezing process
Company aims to help accelerate progress toward a vaccine or treatment for this global health threat
Dr. Melina Schuh has been awarded the BINDER Innovation Prize for her research into the development of fertile egg cells in mammals
Agena Bioscience to provide Horizon’s human genomic reference standards to assess quality and performance of oncology-based assays on the MassARRAY System
iPLEX® HS chemistry enables multiplex detection down to 1% allele frequency
Researchers’ use of ParsortixTM System for studies into multiple cancers confirms the cell separation technology’s ability to harvest viable circulating tumor cells for a broad range of downstream analyses
MassHunter VistaFlux will help cancer researchers better understand metabolic pathways
RNA-seq Explorer Solution generates clear insights for cancer ‘omics’ analyses